Bristol-Myers Squibb's Abecma gets approval for multiple myeloma
Bristol-Myers Squibb's Abecma gets approval for multiple myeloma
Comparatif CRM : l'association de la Relation Client a décerné les prix, grandes marques | CELGE
Denis Fompeyrine: creating a start-up to help prevent depression | HEC Paris
ICPC World Finals 2019 Closing Ceremony by Bob Smith
Bristol-Myers Squibb : pionniers sur l'immuno-oncologie
2012 | Page 426 | Les Echos
Jean Berland's email & phone | TOD'S Group's Group Regional Director, Middle East, India and Africa email
La politique « Culture Client » chez Bristol-Myers Squibb
Bristol Myers Squibb Gives $53M to Support Cancer Immunotherapies
BMS Japan to Integrate Celgene Next Year, HQ Relocation Planned in H1 2022: Chief | PHARMA JAPAN
Japan approves Bristol Myers Squibb's B-cell lymphoma therapy
تويتر \ Céline Morel على تويتر: "J-C Barland, DG @BMSFrance introduit la question de la confiance dans l'industrie de santé #publicTrustInHealth #fondationGEM @Grenoble_EM https://t.co/EHpWIIRkxX"
Liso-Cel Approved in Japan for Relapsed/Refractory Large B-Cell Lymphoma
Bristol-Myers Squibb : Jean-Christophe Barland nommé Senior Vice-Président Europe et Directeur Général France MyPharma Editions | L'Info Industrie & Politique de Santé
200+ "Barland" profiles | LinkedIn
Arrivée de Jean-Christophe Barland, Senior - Bristol
PharmaBoardroom - Interview: Jean-Christophe Barland - Senior Vice President & General Manager France, Bristol-Myers Squibb (BMS)
Naoto T Ueno, MD, PhD (@teamoncology) / Twitter
Calaméo - RIB 2018 "Rencontres Internationales des Biotechnologies"
Arrivée de Jean-Christophe Barland, Senior - Bristol
